ClinVar Miner

Submissions for variant NM_001130438.3(SPTAN1):c.6498C>A (p.Arg2166=)

dbSNP: rs72758823
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Genetic Services Laboratory, University of Chicago RCV000147646 SCV000195095 uncertain significance Developmental and epileptic encephalopathy, 5 2013-03-04 criteria provided, single submitter clinical testing
GeneDx RCV000713521 SCV000521699 likely benign not provided 2021-10-09 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV001088259 SCV000633796 benign Early infantile epileptic encephalopathy with suppression bursts 2024-01-30 criteria provided, single submitter clinical testing
Athena Diagnostics RCV000713521 SCV000844142 benign not provided 2018-08-08 criteria provided, single submitter clinical testing
Ambry Genetics RCV002312981 SCV000848852 likely benign Inborn genetic diseases 2017-01-17 criteria provided, single submitter clinical testing This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Eurofins Ntd Llc (ga) RCV000420949 SCV000860313 likely benign not specified 2018-03-29 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV000147646 SCV002056603 benign Developmental and epileptic encephalopathy, 5 2021-07-15 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004737228 SCV005352468 likely benign SPTAN1-related disorder 2024-06-28 no assertion criteria provided clinical testing This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.